Story perspectives

New FDA Director Sparks Concerns Over Vaccine Policy Shift

12/4/2025

Summary

Story summary

Tracy Beth Hoeg becomes acting director of Center for Drug Evaluation and Research (CDER) at U.S. FDA after Richard Pazdur's retirement.
Hoeg is described as a COVID vaccine skeptic who aims to modernize CDER amid vaccine policy shifts.
Theresa Michele has been reassigned after a decade leading the Office of Nonprescription Drugs, focusing on affordability.
Former FDA commissioners warn changes threaten transparency and signal a major shift in vaccine policy.

1 of 1

Story summary

Tracy Beth Hoeg becomes acting director of Center for Drug Evaluation and Research (CDER) at U.S. FDA after Richard Pazdur's retirement.
Hoeg is described as a COVID vaccine skeptic who aims to modernize CDER amid vaccine policy shifts.
Theresa Michele has been reassigned after a decade leading the Office of Nonprescription Drugs, focusing on affordability.
Former FDA commissioners warn changes threaten transparency and signal a major shift in vaccine policy.